Views & Analysis | Perspectives on pharma industry issues

Oncology

Improving breast cancer outcomes in sub-Saharan Africa

New funding from The Pfizer Foundation will support breast cancer efforts in Kenya by the Academic Model Providing Access to Healthcare (AMPATH).

Sales & Marketing

Televisual glitch over a female green eye

When advertising educates: How interactive creative empowers...

Interactive CTV and cross-screen creative formats make it possible to embed educational elements directly into the advertising experience.

R&D

Allogeneic cell therapy isn’t dead, with Brian Culley

Lineage Cell Therapeutics' Brian Culley discusses allogeneic cell therapy, even beyond the traditional cell therapy realm of oncology.

R&D

Changing how the world finds new medicines: Physics modellin...

Finding treatments for diseases afflicting humanity often proceeds at a crawl, leaving many serious medical needs unmet.

Digital

AI's promise, biotech's peril: How unequal access to computi...

Many biotechs remain locked out of the AI revolution by a combination of cost, complexity, and lack of access to state-of-the-art infrastructure.

R&D

The quiet evolution taking place in paediatric imaging

In children, MRI is increasingly used for imaging of the central nervous system (CNS), chest, abdomen, pelvis and musculoskeletal tissue.

Oncology

Engineering “smarter” cells, with Tim Lu

Senti Bio's Tim Lu discusses “logic-gated” cells, which have multiple receptors allowing them to attack cancer cells while leaving healthy cells alone

Patients

Pills from bottle without label into palm of a man's hand

Meeting the growing demand for animal-free medicines

Pharmaceutical manufacturers have begun, albeit tentatively, to acknowledge and respond to evolving dietary sensibilities.

Sales & Marketing

When advertising educates: How interactive creative empowers...

Interactive CTV and cross-screen creative formats make it possible to embed educational elements directly into the advertising experience.

Sales & Marketing

Bright lightbulb ideas in pharma marketing

Closing the digital gap: Paid media’s essential role in omni...

Paid media helps to extend content and messaging and reach HCPs where they are already active.

Digital

AI's promise, biotech's peril: How unequal access to computi...

Many biotechs remain locked out of the AI revolution by a combination of cost, complexity, and lack of access to state-of-the-art infrastructure.

Digital

pharmaphorum podcast Episode 242, Yann Gaston-Mathe, Iktos

JPM2026: Broadening AI drug discovery to include the lab, wi...

Yann Gaston-Mathe, founder and CEO of Iktos, discusses AI drug discovery's shift to real-world operations that are able to incorporate wet lab data.

Market Access

European biopharma at a crossroads

If Europe can bridge its operational gaps while leveraging its scientific base, it can carve out a distinctive and sustainable leadership position.

Market Access

The Westin St Francis, where the main JPM conference is held.

Five Takeaways from JP Morgan Week 2026

JP Morgan Week may not have produced megadeals this year, but it still yielded plenty of food for thought. Here's five quick insights from San Fran.

Oncology

Improving breast cancer outcomes in sub-Saharan Africa

New funding from The Pfizer Foundation will support breast cancer efforts in Kenya by the Academic Model Providing Access to Healthcare (AMPATH).

Oncology

Engineering “smarter” cells, with Tim Lu

Senti Bio's Tim Lu discusses “logic-gated” cells, which have multiple receptors allowing them to attack cancer cells while leaving healthy cells alone

Oncology